Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-24

Clinical Trial Update: Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants [NA]

View source ↗

Summary

This completed trial evaluated ultrashort-term heat inactivation of cytomegalovirus-containing raw breast milk to prevent CMV infection in preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Cytomegalovirus Infection, Preterm Infants | NA | Status: COMPLETED